Back
Inozyme Pharma Stock Predictions
MarketBeat Alert: Strong sell signal just issued for these 20 stocks
Go here now to get free instant access to all 20 stocks to sell.
Sell
50
INZY
Inozyme Pharma
Last Price:
4.46
Seasonality Move:
-5.14%
7 Day Trial
ALL ACCESS PASS
$
7
He cracked the code to crypto
Now he says a new two-year bull market has begun. And he likes one altcoin above all others.Inozyme Pharma Stock Forecast
-
Is Inozyme Pharma Stock Undervalued?
The current Inozyme Pharma [INZY] share price is $4.44. The Score for INZY is 50, which is 0% below its historic median score of 50, and infers higher risk than normal. - INZY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Inozyme Pharma Stock Go Up Next Year?
Data Unavailable
Inozyme Pharma Stock Rating
Data Unavailable
Inozyme Pharma Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
inozyme.com
52-Week Data
52-Week High:
7.80
52-Week Low:
2.69
Prediction Charts
Market Cap:
274.27M
Price in USD:
4.44
Volume:
510.97K
Beta:
1.38
Technical Analysis
SMA50:
5.81
SMA100:
5.18
SMA200:
4.73
52-Wk Change:
-18.83%
Stock Predictions
-
Is Inozyme Pharma stock public?
Yes, Inozyme Pharma is a publicly traded company. -
What is the Inozyme Pharma stock quote today?
The Inozyme Pharma stock price is 4.44 USD today. -
How to buy Inozyme Pharma stock online?
You can buy Inozyme Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-9 | 5.60 | 5.48 | 5.70 | 4.88 |
| Apr-10 | 5.25 | 5.24 | 5.31 | 5.10 |
| Apr-11 | 5.33 | 5.22 | 5.49 | 5.15 |
| Apr-12 | 5.19 | 5.14 | 5.21 | 4.89 |
| Apr-15 | 5.11 | 4.73 | 5.11 | 4.67 |
| Apr-16 | 4.67 | 4.86 | 4.99 | 4.60 |
| Apr-17 | 4.92 | 4.65 | 4.98 | 4.62 |
| Apr-18 | 4.64 | 4.58 | 4.82 | 4.57 |
| Apr-19 | 4.54 | 4.51 | 4.63 | 4.38 |
| Apr-22 | 4.57 | 4.39 | 4.57 | 4.39 |
| Apr-23 | 4.43 | 4.40 | 4.62 | 4.40 |
| Apr-24 | 4.40 | 4.40 | 4.49 | 4.35 |
| Apr-25 | 4.39 | 4.33 | 4.49 | 4.18 |
| Apr-26 | 4.33 | 4.44 | 4.51 | 4.23 |
Inozyme Pharma Earnings
Data Unavailable
Inozyme Pharma Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and an increase next year of $0.01 per share.
* Inozyme Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.